![Mathew David](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathew David
Director of Finance/CFO at
ACTINIUM PHARMACEUTICALS, INC.
Net worth: 280 000 $ as of 29/09/2026
Profile
Dr. Mathew T.
David, MD, is a Chief Financial Officer at Actinium Pharmaceuticals, Inc. Dr. David was previously employed as a Chief Business Officer & Executive Vice President by CorMedix, Inc. and a Head-Strategy by Ovid Therapeutics, Inc. He received his undergraduate degree from Dartmouth College and a doctorate degree from New York University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/10/2026 | 250,000 ( 0.8% ) | 280 000 $ | 29/09/2026 |
Mathew David active positions
| Companies | Position | Start |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 13/10/2026 |
Former positions of Mathew David
| Companies | Position | End |
|---|---|---|
| OVID THERAPEUTICS INC. | Corporate Officer/Principal | - |
| CORMEDIX INC. | Chief Executive Officer | 09/05/2022 |
Education of Mathew David
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
15
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
CorMedix, Inc.
 CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Mathew David
